ETHYL (1S,2R)-2-(CBZ-AMINO)CYCLOPENTANECARBOXYLATE, 95.0%, 50mg

1'-(Tert-butoxycarbonyl)-3H-spiro[isobenzofuran-1,4'-piperidine]-3-carboxylic acid, 97%, 1g

N-[(1R,2R)-2-Amino-1,2-diphenylethyl]-3,5-bis(trifluoromethyl)benzenesulfonamide, 97%, 250mg

1mol/L NaPF6 EC:DMC (1:1v/v%), 100g

Methyl 7-hydroxyheptanoate, 97.0%, 5g

7-(Trifluoromethyl)-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 1g

1-Ethyl-1H-imidazole-2-carbaldehyde, 95.0%, 25g

1-Ethyl-1H-pyrazole, 97.0%, 5g

4-(Trifluoromethoxy)benzonitrile>98.0%(GC)5g

Sample reservoir Liqui, 150 ml, PTFE, FEP, 1 piece

3-propyl-1H-pyrazole-5-carboxylic acid, 95.0%, 250mg

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid, 95.0%, 5g

2,4,4-Trimethyl-2-pentene, 5g